Chronic Lymphocytic Leukemia Real-World Data
Chronic lymphocytic leukemia (CLL) is the most frequently diagnosed type of leukemia in adults, accounting for about one-third of all leukemia cases.
Qdata® can help lead to better treatments.
Qdata® Chronic Lymphocytic Leukemia is an exclusive dataset providing a longitudinal view of disease progression and treatment patterns, including risk profile, therapy sequencing, and real-world outcomes.
Key Data Elements
Demographics
Molecular Markers
IgHV Mutation Status
Del(17p) Cytogenetics
BTK Inhibitors
Anti-CD20 Agents
Relapsed/Refractory
Performance Status
Survival & Outcomes
About Qdata® Chronic Lymphocytic Leukemia
CLL is a slow-growing cancer of the blood and bone marrow. It causes the body to produce an excess of abnormal white blood cells called B lymphocytes, which crowd out healthy cells and weaken the immune system.
CLL medical research is aided by deeply abstracted, longitudinal CLL patient records that capture clinical detail required to understand disease biology and treatment response. The dataset includes molecular features along with comprehensive therapy exposure. Each record is curated under oncology oversight and structured to support regulatory and development use.
Evidence in Action
Comprehensive Coverage Across the Full CLL Continuum
With 67% of patients with outcome data, 81% of patients with performance status, and 9.1 years average length of follow-up, the dataset reflects the specialized care setting central to chronic lymphocytic leukemia management.
Comprehensive Coverage of CLL Treatment Modalities
The chronic lymphocytic leukemia dataset spans the full treatment landscape, from legacy chemoimmunotherapy regimens to contemporary targeted therapies. Each line of therapy is captured in sequence, providing a clear view of real world treatment patterns and transitions across the patient journey.
Custom Data Curation
Need data tailored to your exact study design requirements?
Our purpose-built, fit-for-purpose datasets are designed to support rigorous research and confident decision-making. These datasets can be tailored
around custom inclusion and exclusion criteria, in addition to including all standard abstracted data elements.
Ready to Explore the Chronic Lymphocytic Leukemia Dataset?
Connect with our team to discuss your research objectives and receive a tailored data overview.